What is the dosing range for AHK-Cu (Alanine-Histidine-Lysine Copper)?

AHK-Cu (Alanine-Histidine-Lysine Copper) is typically dosed at 0.1% (low), 0.5% (moderate), or 1% (high) %, administered Daily topical application (scalp). These ranges are aggregated from preclinical research and community protocols — not medical dosing guidance.

What are the reported side effects of AHK-Cu (Alanine-Histidine-Lysine Copper)?

Reported side effects of AHK-Cu (Alanine-Histidine-Lysine Copper) include: Mild scalp irritation, Contact dermatitis (rare), Temporary scalp redness or tingling, Transient scalp shedding at initiation (shedding phase).

Anti-Aging

AHK-Cu (Alanine-Histidine-Lysine Copper)

Also known as: AHK copper peptide, Ala-His-Lys copper, hair growth copper peptide, AHK-copper complex

Share:Share on Reddit

AHK-Cu is a cosmetic research compound. Topical use only in standard formulations.

📚 Content aggregated from:2 peer-reviewed sources·r/Peptides community·PubMed / NCBI

Overview

Copper-chelating tripeptide structurally related to GHK-Cu but optimized for scalp and hair follicle applications. AHK-Cu activates hair follicle stem cells and prolongs the anagen (active growth) phase, making it a key research compound for androgenetic alopecia and diffuse hair loss. Used topically as an alternative or complement to minoxidil and finasteride.

Research Summary

AHK-Cu activates β-catenin/Wnt signaling in dermal papilla cells and promotes VEGF expression around hair follicles. Studies demonstrate extended anagen phase duration, increased follicle size, and upregulation of hair growth factors in treated scalp tissue. The copper component supports tyrosinase activity for follicle pigmentation and metalloenzymes involved in extracellular matrix remodeling around follicles.

Dosing Range

low

0.1%

moderate

0.5%

high

Units: % · Frequency: Daily topical application (scalp)

Dosing ranges are aggregated from preclinical research and community protocols. Not medical dosing guidance.

Administration Routes

Topical (scalp serum/solution)Subcutaneous (microneedling-assisted delivery)

Reconstitution Notes

Topical preparations: dissolve in appropriate vehicle (water/ethanol/glycerin base) at pH 4–5 for optimal copper complex stability. Room temperature stable in sealed formulation. Microneedling delivery: prepare at 0.5–1% in saline immediately before use.

Step-by-step reconstitution guide →

Supplies you'll need

Insulin Syringes (U-100)Reconstitution Needles Lambda BAC Water Alcohol Prep Pads

Affiliate links — Research Stack may earn a small commission at no extra cost to you.

Reported Side Effects

Mild scalp irritation
Contact dermatitis (rare)
Temporary scalp redness or tingling
Transient scalp shedding at initiation (shedding phase)

Research Papers

2 peer-reviewed sources

Copper peptides and hair follicle stimulation: AHK-Cu effects on anagen

Journal of Investigative Dermatology2006

Tripeptide copper complexes as hair growth modulators

Journal of the American Academy of Dermatology1997

Community Experiences

Aggregated from public forums. Anecdotal — not clinical evidence.

r/tressless

Hair loss community reports on topical AHK-Cu protocols, combination with minoxidil, and before/after results.

View original thread

r/Peptides

Research discussion on AHK-Cu mechanism and comparison to GHK-Cu for scalp applications.

View original thread

Overview

AHK-Cu (Ala-His-Lys copper tripeptide) is a structural variant of the famous GHK-Cu copper peptide, engineered specifically to optimize activity at hair follicles. The single amino acid substitution from Gly to Ala at the N-terminus alters receptor binding specificity and improves follicle-specific signaling without sacrificing copper chelation ability.

The hair follicle is a uniquely regenerative structure — one of the few organs in the body that undergoes complete cyclical regeneration throughout adult life. The three phases (anagen/growth, catagen/transition, telogen/rest) are controlled by complex molecular signals involving Wnt/β-catenin, BMP, and growth factor pathways. AHK-Cu targets several of these regulatory nodes.

Mechanism

Wnt/β-Catenin Pathway Activation

The primary mechanism distinguishing AHK-Cu as a hair growth compound:

β-catenin stabilization in dermal papilla cells: Prevents GSK-3β-mediated phosphorylation and degradation of β-catenin
Nuclear β-catenin accumulation: Activates TCF/LEF transcription factors driving follicle growth genes
Dermal papilla cell proliferation: Increased cell division maintains follicle signaling capacity
Anagen phase extension: Delays onset of catagen, prolonging the active growth window

Angiogenesis and Follicle Nutrition

AHK-Cu upregulates VEGF (vascular endothelial growth factor) expression in perifollicular tissue:

Enhanced capillary density around follicle bulb
Improved nutrient and oxygen delivery
Removal of metabolic waste from actively proliferating follicle cells

DHT / Miniaturization Counter-Effects

Androgenetic alopecia involves DHT-driven progressive follicle miniaturization via androgen receptor signaling in susceptible follicles. AHK-Cu's Wnt pathway activation is proposed to counteract some miniaturization effects by restoring dermal papilla cell volume and activity, though it does not block DHT production (unlike finasteride).

AHK-Cu vs. GHK-Cu for Hair

| Parameter | AHK-Cu | GHK-Cu | |-----------|--------|--------| | Primary target | Hair follicle | Wound healing, skin | | Wnt/β-catenin | Strong | Moderate | | Collagen synthesis | Moderate | Strong | | Typical use | Scalp topical | Skin/wound topical | | Optimal pH | 4–5 | 4–5 | | Research evidence | Moderate | Extensive |

Combination Protocols

AHK-Cu is frequently combined in research protocols with:

Minoxidil: Potassium channel opener → vasodilation + anagen extension (different mechanism — additive)
Microneedling: Physical dermal papilla stimulation enhances copper peptide penetration
Retinol: Epidermal renewal increases copper peptide absorption